Mauro, ViganĂ²
Lorenzo, Mantovani
Paolo, Cozzolino
Sergio, Harari http://orcid.org/0000-0002-6414-3460
Article History
Received: 28 April 2020
Accepted: 1 June 2020
First Online: 9 June 2020
Change Date: 20 October 2020
Change Type: Correction
Change Details: In the original publication of the article, the given name and family name of all the author were swapped. The correct author name is given in this erratum.
Compliance with ethical standards
:
: M. ViganĂ²: Board/speaker Bureau for BMS, MSD, Alfasigma, Gilead Scinces, Fujirebio and Intercept. S. Harari: Grants and personal fees from Roche, Actelion and boehringer Ingelheim.
: This study was conducted in accordance with the ethical standard of our Institutional committeee on Human experimentation.
: None.
Free to read: This content has been made available to all.